Covered recipient · General Payments record
KATRINA M DE VRIES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$2,006.43
- Reported across 111 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $318.10 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $76.00 | 4 |
| ABBVIE INC. | $65.74 | 3 |
| Acerta Pharma LLC | $33.40 | 2 |
| Lundbeck LLC | $25.72 | 1 |
| Exact Sciences Corporation | $23.11 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.47 | 1 |
| Abbott Laboratories | $16.29 | 1 |
| Amgen Inc. | $16.05 | 1 |
| Lilly USA, LLC | $15.48 | 1 |
| Janssen Pharmaceuticals, Inc | $14.97 | 1 |
| Novo Nordisk AS | $14.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.29 | 01/19/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1125083257 | CMS |
| ABBVIE INC. | $26.27 | 01/12/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1107000818 | CMS |
| ABBVIE INC. | $18.64 | 01/25/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1107000820 | CMS |
| ABBVIE INC. | $20.83 | 02/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1107000822 | CMS |
| Amgen Inc. | $16.05 | 01/23/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1117235547 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.39 | 01/24/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1110538617 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.01 | 02/07/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1110548198 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.47 | 01/29/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1118024278 | CMS |
| Exact Sciences Corporation | $23.11 | 01/25/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1128384247 | CMS |
| Janssen Pharmaceuticals, Inc | $14.97 | 01/09/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1078160459 | CMS |
| Lilly USA, LLC | $15.48 | 01/17/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135766281 | CMS |
| Lundbeck LLC | $25.72 | 02/06/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1146012327 | CMS |
| Novo Nordisk Inc | $14.87 | 01/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1108570650 | CMS |
| PFIZER INC. | $18.21 | 01/02/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131824886 | CMS |
| PFIZER INC. | $20.01 | 01/08/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131824288 | CMS |
| PFIZER INC. | $13.33 | 02/05/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131817924 | CMS |
| PFIZER INC. | $24.45 | 02/13/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131825264 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.